Franklin Resources’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.68M | Buy |
115,488
+6,051
| +6% | +$58.4K | ﹤0.01% | 2072 |
|
|
2026
Q1 | $812K | Buy |
109,437
+23,748
| +28% | +$250K | ﹤0.01% | 2264 |
|
|
2025
Q4 | $1.01M | Sell |
85,689
-1,076,459
| -93% | -$11.6M | ﹤0.01% | 2076 |
|
|
2025
Q3 | $8.97M | Sell |
1,162,148
-316,132
| -21% | -$2.21M | ﹤0.01% | 1203 |
|
|
2025
Q2 | $10.8M | Buy |
1,478,280
+12,381
| +0.8% | +$99.9K | ﹤0.01% | 1109 |
|
|
2025
Q1 | $13.9M | Buy |
1,465,899
+4,493
| +0.3% | +$56.1K | ﹤0.01% | 1003 |
|
|
2024
Q4 | $24.1M | Sell |
1,461,406
-582,434
| -28% | -$9.05M | 0.01% | 845 |
|
|
2024
Q3 | $28.2M | Buy |
2,043,840
+39,740
| +2% | +$622K | 0.01% | 782 |
|
|
2024
Q2 | $27.8M | Sell |
2,004,100
-122,498
| -6% | -$1.74M | 0.01% | 750 |
|
|
2024
Q1 | $33.4M | Buy |
2,126,598
+655,556
| +45% | +$10.1M | 0.01% | 711 |
|
|
2023
Q4 | $23.8M | Sell |
1,471,042
-2,854
| -0.2% | -$46.7K | 0.01% | 708 |
|
|
2023
Q3 | $18.1M | Buy |
1,473,896
+1,000
| +0.1% | +$14.9K | 0.01% | 771 |
|
|
2023
Q2 | $23.7M | Buy |
1,472,896
+77,310
| +6% | +$1.27M | 0.01% | 721 |
|
|
2023
Q1 | $24.3M | Buy |
1,395,586
+142
| +0% | +$2.02K | 0.01% | 724 |
|
|
2022
Q4 | $12.9M | Sell |
1,395,444
-6,157
| -0.4% | -$57.4K | 0.01% | 890 |
|
|
2022
Q3 | $12.1M | Buy |
1,401,601
+17,844
| +1% | +$177K | 0.01% | 885 |
|
|
2022
Q2 | $11.3M | Buy |
1,383,757
+1,738
| +0.1% | +$16.6K | 0.01% | 925 |
|
|
2022
Q1 | $16.8M | Buy |
1,382,019
+237,512
| +21% | +$5M | 0.01% | 894 |
|
|
2021
Q4 | $39M | Sell |
1,144,507
-9,982
| -0.9% | -$391K | 0.01% | 719 |
|
|
2021
Q3 | $55.7M | Buy |
1,154,489
+3,533
| +0.3% | +$164K | 0.02% | 616 |
|
|
2021
Q2 | $52M | Sell |
1,150,956
-2,474
| -0.2% | -$110K | 0.02% | 641 |
|
|
2021
Q1 | $55.6M | Buy |
1,153,430
+1,457
| +0.1% | +$75.9K | 0.02% | 588 |
|
|
2020
Q4 | $62M | Buy |
1,151,973
+600
| +0.1% | +$27.1K | 0.03% | 530 |
|
|
2020
Q3 | $42.5M | Sell |
1,151,373
-45,726
| -4% | -$1.7M | 0.02% | 592 |
|
|
2020
Q2 | $44M | Sell |
1,197,099
-10,367
| -0.9% | -$287K | 0.02% | 560 |
|
|
2020
Q1 | $33.3M | Sell |
1,207,466
-60,812
| -5% | -$1.82M | 0.02% | 559 |
|
|
2019
Q4 | $37.1M | Sell |
1,268,278
-234,588
| -16% | -$5.59M | 0.02% | 612 |
|
|
2019
Q3 | $28.7M | Buy |
1,502,866
+4,664
| +0.3% | +$109K | 0.02% | 663 |
|
|
2019
Q2 | $32.9M | Buy |
1,498,202
+5,437
| +0.4% | +$119K | 0.02% | 643 |
|
|
2019
Q1 | $30.5M | Sell |
1,492,765
-1,041
| -0.1% | -$18.1K | 0.02% | 635 |
|
|
2018
Q4 | $18.8M | Sell |
1,493,806
-2,107
| -0.1% | -$31.4K | 0.01% | 716 |
|
|
2018
Q3 | $23M | Buy |
1,495,913
+675,525
| +82% | +$9.34M | 0.01% | 744 |
|
|
2018
Q2 | $10.8M | Sell |
820,388
-737,005
| -47% | -$8.11M | 0.01% | 908 |
|
|
2018
Q1 | $12.7M | Buy |
1,557,393
+784,493
| +101% | +$6.36M | 0.01% | 885 |
|
|
2017
Q4 | $6.85M | Buy |
+772,900
| New | +$7.13M | ﹤0.01% | 1021 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
Franklin Resources's NEO Position: Q2 2026 in Review
Franklin Resources increased its NeoGenomics (NEO) stake by 5.5% in Q2 2026, buying an estimated $58.4K and bringing the position to 115,488 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.
Franklin Resources first reported a position in NEO in Q4 2017 and has held it in 35 quarters since. The position peaked at $62M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Franklin Resources held 115,488 shares of NeoGenomics worth $1.68M as of Q2 2026.
- Franklin Resources bought 6,051 NeoGenomics shares in Q2 2026, an estimated $58.4K.
- NeoGenomics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2072 holding.
- Franklin Resources first reported a position in NeoGenomics in Q4 2017 and has held it in 35 quarters since.
- Franklin Resources's NeoGenomics position peaked at $62M in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.